哈三联：8月25日召开董事会会议

Group 1 - The company Hasi Lian (SZ 002900) held its 23rd meeting of the fourth board of directors on August 25, 2025, via telecommunication voting, discussing the proposal for the 2025 semi-annual report [1] - For the year 2024, Hasi Lian's revenue composition is as follows: pharmaceutical industry 87.34%, veterinary medicine 6.64%, other businesses 5.44%, cosmetics 0.45%, and functional foods 0.12% [1] - As of the report date, Hasi Lian's market capitalization is 4.7 billion yuan [1] Group 2 - The pet industry is experiencing significant growth, with a market size of 300 billion yuan, leading to a surge in stock prices for related companies [1]